Olaris, Inc. to present novel myOLARIS™-KTdx assay detecting graft status in kidney transplant recipients at American Transplant Congress 2022 Meeting

Framingham, Massachusetts (PRWEB) June 06, 2022 -- Olaris, Inc., a precision medicine company leveraging metabolomics and machine learning for the discovery

Related Keywords

Boston ,Massachusetts ,United States ,Framingham ,American ,Dirk Kuypers ,Polaris Inc ,Laboratory Of Nephrology ,American Transplant Congress ,University Of Leuven ,International Transplant Science ,Elizabetho Day ,Comprehensive Early Responsive Evaluation ,Biomarkers Related ,Press Release ,